HDAC2 deficiency sensitizes colon cancer cells to TNFalpha-induced apoptosis through inhibition of NF-kappaB activity (Q80805979)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18314102%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

title

HDAC2 deficiency sensitizes colon cancer cells to TNFalpha-induced apoptosis through inhibition of NF-kappaB activity (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18314102%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

1 reference

1 reference

Pawan Kaler

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18314102%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Takehiko Sasazuki

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18314102%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Senji Shirasawa

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18314102%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Leonard Augenlicht

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18314102%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Lidija Klampfer

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18314102%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

language of work or name

English

0 references

publication date

19 January 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18314102%20AND%20SRC:MED&resulttype=core&format=json

Experimental Cell Research

3 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18314102%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

volume

314

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18314102%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18314102%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

page(s)

1507-1518

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18314102%20AND%20SRC:MED&resulttype=core&format=json

A CBP/p300 homolog specifies multiple differentiation pathways in Caenorhabditis elegans.

3 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.01.010

Therapeutic targeting of transcription in acute promyelocytic leukemia by use of an inhibitor of histone deacetylase.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.01.010

Histone-deacetylase inhibitors: novel drugs for the treatment of cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.01.010

Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.01.010

The p65 (RelA) subunit of NF-kappaB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.01.010

Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-kappaB.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.01.010

Stat3 dimerization regulated by reversible acetylation of a single lysine residue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.01.010

The antitumor histone deacetylase inhibitor suberoylanilide hydroxamic acid exhibits antiinflammatory properties via suppression of cytokines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.01.010

Butyrate suppression of colonocyte NF-kappa B activation and cellular proteasome activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.01.010

TNF-alpha in cancer treatment: molecular insights, antitumor effects, and clinical utility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.01.010

Tumour necrosis factor. Another chapter in the long history of endotoxin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.01.010

TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.01.010

I kappa B: a specific inhibitor of the NF-kappa B transcription factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.01.010

Control of I kappa B-alpha proteolysis by site-specific, signal-induced phosphorylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.01.010

The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.01.010

Rapid proteolysis of I kappa B-alpha is necessary for activation of transcription factor NF-kappa B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.01.010

The nuclear factor kappa-B signaling pathway participates in dysregulation of vascular smooth muscle cells in vitro and in human atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.01.010

NF-kappaB: linking inflammation and immunity to cancer development and progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.01.010

Duration of nuclear NF-kappaB action regulated by reversible acetylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.01.010

Involvement of HDAC1 and the PI3K/PKC signaling pathways in NF-kappaB activation by the HDAC inhibitor apicidin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.01.010

Suberoylanilide hydroxamic acid potentiates apoptosis, inhibits invasion, and abolishes osteoclastogenesis by suppressing nuclear factor-kappaB activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.01.010

Histone deacetylase inhibitor trichostatin A and proteasome inhibitor PS-341 synergistically induce apoptosis in pancreatic cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.01.010

Ineffectiveness of histone deacetylase inhibitors to induce apoptosis involves the transcriptional activation of NF-kappa B through the Akt pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.01.010

Altered growth of human colon cancer cell lines disrupted at activated Ki-ras

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.01.010

Increased production of tumour necrosis factor-alpha interleukin-1 beta, and interleukin-6 by morphologically normal intestinal biopsies from patients with Crohn's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.01.010

Tumour necrosis factor alpha in stool as a marker of intestinal inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.01.010

Synergistic induction of apoptosis in breast cancer cells by cotreatment with butyrate and TNF-alpha, TRAIL, or anti-Fas agonist antibody involves enhancement of death receptors' signaling and requires P21(waf1).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.01.010

Histone deacetylase inhibitors suppress the inducibility of nuclear factor-kappaB by tumor necrosis factor-alpha receptor-1 down-regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.01.010

Trichostatin A (TSA) sensitizes the human prostatic cancer cell line DU145 to death receptor ligands treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.01.010

Histone deacetylase inhibitors induce cell death selectively in cells that harbor activated kRasV12: The role of signal transducers and activators of transcription 1 and p21.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.01.010

Oncogenic Ras promotes butyrate-induced apoptosis through inhibition of gelsolin expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.01.010

Commitment to apoptosis is associated with changes in mitochondrial biogenesis and activity in cell lines conditionally immortalized with simian virus 40.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.01.010

Pro-oxidants and mitochondrial Ca2+: their relationship to apoptosis and oncogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.01.010

Caspase-3-generated fragment of gelsolin: effector of morphological change in apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.01.010

Nature's TRAIL--on a path to cancer immunotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.01.010

Requirement of NF-kappaB activation to suppress p53-independent apoptosis induced by oncogenic Ras.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.01.010

Ursodeoxycholic acid inhibits interleukin 1 beta [corrected] and deoxycholic acid-induced activation of NF-kappaB and AP-1 in human colon cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.01.010

The phosphorylation status of nuclear NF-kappa B determines its association with CBP/p300 or HDAC-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.01.010

NF-kappa B subunit regulation in nontransformed CD4+ T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.01.010

Valproate inhibition of histone deacetylase 2 affects differentiation and decreases proliferation of endometrial stromal sarcoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.01.010

The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.01.010

Induction of HDAC2 expression upon loss of APC in colorectal tumorigenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.01.010

Apoptotic and autophagic cell death induced by histone deacetylase inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.01.010

Histone deacetylase inhibitors in programmed cell death and cancer therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.01.010

Histone deacetylases and cancer: causes and therapies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.01.010

Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.01.010

HDAC inhibitors as anti-inflammatory agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.01.010

The dark side of Ras: regulation of apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.01.010

Hyperactive Ras in developmental disorders and cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.01.010

Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.01.010

Oncogenic Ras-induced secretion of IL6 is required for tumorigenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.01.010

Role of tumor necrosis factor receptor 2 (TNFR2) in colonic epithelial hyperplasia and chronic intestinal inflammation in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.01.010

TNF-alpha neutralization ameliorates the severity of murine Crohn's-like ileitis by abrogation of intestinal epithelial cell apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.01.010

Oncogenic Ki-ras inhibits the expression of interferon-responsive genes through inhibition of STAT1 and STAT2 expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.01.010

Butyrate inhibits inflammatory responses through NFkappaB inhibition: implications for Crohn's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.01.010

The luminal short-chain fatty acid butyrate modulates NF-kappaB activity in a human colonic epithelial cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.01.010

Involvement of different nuclear hormone receptors in butyrate-mediated inhibition of inducible NF kappa B signalling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.01.010

Inhibition of Histone Deacetylase Class I but not Class II Is Critical for the Sensitization of Leukemic Cells to Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand–Induced Apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.01.010

10.1016/J.YEXCR.2008.01.010

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18314102%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

1 reference